Open Access
BIO Web Conf.
Volume 59, 2023
2023 5th International Conference on Biotechnology and Biomedicine (ICBB 2023)
Article Number 02005
Number of page(s) 4
Section Precision Medicine and Drug Development and Preparation
Published online 08 May 2023
  • H. Wang, Q. Zhao, Y. Bai, L. Zhang, and X. Yu, ‘Poverty and Subjective Poverty in Rural China’, Soc. Indic. Res., vol. 150, no. 1, pp. 219–242, Jul. 2020, doi: 10.1007/s11205-020-02303-0. [CrossRef] [Google Scholar]
  • H. Molaee, S. N. Emadi, J. M. N. M'Imunya, E. Davoudi-Monfared, A. Mohammed, and Z. Razavi, ‘Chilblain or perniosis-like skin lesions in children during the COVID -19 pandemic: A systematic review of articles’, Dermatol. Ther., vol. 35, no. 3, Mar. 2022, doi: 10.1111/dth.15298. [CrossRef] [Google Scholar]
  • I. Gardinal-Galera, C. Pajot, C. Paul, and J. Mazereeuw-Hautier, ‘Childhood chilblains is an uncommon and invalidant disease’, Arch. Dis. Child., vol. 95, no. 7, pp. 567–568, Jul. 2010, doi: 10.1136/adc.2010.183145. [CrossRef] [PubMed] [Google Scholar]
  • D. Andina et al., ‘Chilblains in children in the setting of COVID-19 pandemic’, Pediatr. Dermatol., vol. 37, no. 3, pp. 406–411, 2020, doi: 10.1111/pde.14215. [CrossRef] [PubMed] [Google Scholar]
  • S. Dubey, N. Joshi, O. Stevenson, C. Gordon, and J. A. Reynolds, ‘Chilblains in immune-mediated inflammatory diseases: a review’, Rheumatology, p. keac231, Apr. 2022, doi: 10.1093/rheumatology/keac231. [Google Scholar]
  • M. Viguier et al., ‘Clinical and Histopathologic Features and Immunologic Variables in Patients with Severe Chilblains: A Study of the Relationship to Lupus Erythematosus’, Medicine (Baltimore), vol. 80, no. 3, pp. 180–188, May 2001. [CrossRef] [PubMed] [Google Scholar]
  • M. Pratt, F. Mahmood, and M. G. Kirchhof, ‘Pharmacologic Treatment of Idiopathic Chilblains (Pernio): A Systematic Review’, J. Cutan. Med. Surg., vol. 25, no. 5, pp. 530–542, Sep. 2021, doi: 10.1177/1203475421995130. [CrossRef] [PubMed] [Google Scholar]
  • A. M. Pisoschi, A. Pop, C. Georgescu, V. Turcuş, N. K. Olah, and E. Mathe, ‘An overview of natural antimicrobials role in food’, Eur. J. Med. Chem., vol. 143, pp. 922–935, Jan. 2018, doi: 10.1016/j.ejmech.2017.11.095. [CrossRef] [Google Scholar]
  • M. Zhang et al., ‘Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents’, Phytother. Res., vol. 35, no. 2, pp. 711–742, Feb. 2021, doi: 10.1002/ptr.6858. [CrossRef] [PubMed] [Google Scholar]
  • H. Li et al., ‘Ginger for health care: An overview of systematic reviews’, Complement. Ther. Med., vol. 45, pp. 114–123, Aug. 2019, doi: 10.1016/j.ctim.2019.06.002. [CrossRef] [Google Scholar]
  • S. D. C. Beristain-Bauza, P. Hernández-Carranza, T. S. Cid-Pérez, R. Ávila-Sosa, I. I. Ruiz-Lopez, and C.E. Ochoa-Velasco, ‘Antimicrobial Activity of Ginger (Zingiber Officinale) and Its Application in Food Products’, Food Rev. Int., vol. 35, no. 5, pp. 407–426, Jul. 2019, doi: 10.1080/87559129.2019.1573829. [CrossRef] [Google Scholar]
  • S. Sang, H. D. Snook, F. S. Tareq, and Y. Fasina, ‘Precision Research on Ginger: The Type of Ginger Matters’, J. Agric. Food Chem., vol. 68, no. 32, pp. 8517–8523, Aug. 2020, doi: 10.1021/acs.jafc.0c03888. [CrossRef] [PubMed] [Google Scholar]
  • B. F. Page, L. Hinton, E. Harrop, and C. Vincent, ‘The challenges of caring for children who require complex medical care at home: “The go between for everyone is the parent and as the parent that’s an awful lot of responsibility”’, Health Expect., vol. 23, no. 5, pp. 1144–1154, Oct. 2020, doi: 10.1111/hex.13092. [CrossRef] [PubMed] [Google Scholar]
  • N. A. Williams, A. Ben Brik, J. M. Petkus, and H. Clark, ‘Importance of play for young children facing illness and hospitalization: rationale, opportunities, and a case study illustration’, Early Child Dev. Care, vol. 191, no. 1, pp. 58–67, Jan. 2021, doi: 10.1080/03004430.2019.1601088. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.